nct02637284 bpc-157 results published Stable Gastric Pentadecapeptide BPC 157 as a Therapy and Safety Key: A Special Beneficial Pleiotropic Effect Controlling and Modulating Angiogenesis and the NO-System A human BPC-157 trial was
A human BPC 157 trial was registered. The results were submitted. Then they disappeared from public view. In 2015, a Phase I, randomized, placebo controlled clinical trial (NCT02637284) was launched PDF) BPC 157 and GHK Cu in Wound Healing and Tissue Repair: A Review of Clinical Efficacy and Safety Stable gastric pentadecapeptide BPC 157 in the treatment of colitis and ischemia and reperfusion in rats: New insights PMC Emerging Use of BPC 157 in Orthopaedic Sports Medicine: A Systematic Review Nikhil Vasireddi, Henrik Hahamyan, Michael J. Salata, Michael Karns, Jacob G. Calcei, James E. Voos, John M. Apostolakos, 2025 nct02637284 bpc 157 trial status All the hype about peptides But what are they actuallyand have they really been tested in humans for muscle BPC 157 has already hit the mainstream, but should it hit your bloodstream?
Pay in 4 interest-free payments of $6.68 Learn more
Shipping Estimate
USA
- USA
- CAN
- USA
- CAN
Ships within 48 hours · Estimated delivery Aug 2 - Aug 7


